These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)]. Blume N; Milatovic D Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674 [TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies against surface antigens of cancer cells. Experimental preparation for early diagnosis and immuno-assisted therapy]. Zenner HP Fortschr Med; 1983 May; 101(19):891-2, 894. PubMed ID: 6873841 [TBL] [Abstract][Full Text] [Related]
4. [Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)]. Zenner HP Arch Otorhinolaryngol; 1981; 233(2):161-72. PubMed ID: 6172103 [TBL] [Abstract][Full Text] [Related]
5. [Does an immune reactivity to human laryngeal cancer exist?]. Cortesina G; Cavallo GP; Sartoris A; Beatrice F; Morra B; Bussi M; Poggio E G Batteriol Virol Immunol; 1979; 72(1-6):169-90. PubMed ID: 399929 [TBL] [Abstract][Full Text] [Related]
6. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient. Kan-Mitchell J; White WL; Mitchell MS Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881 [TBL] [Abstract][Full Text] [Related]
7. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells. Savage HE; Rossen RD; Hersh EM; Freedman RS; Bowen JM; Plager C Cancer Res; 1986 Apr; 46(4 Pt 2):2127-33. PubMed ID: 3948184 [TBL] [Abstract][Full Text] [Related]
8. [Production and preclinical use of a monoclonal immunotoxin against laryngeal cancer cells]. Zenner HP Laryngol Rhinol Otol (Stuttg); 1984 Nov; 63(11):566-9. PubMed ID: 6521585 [TBL] [Abstract][Full Text] [Related]
9. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials. Hollinshead AC Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778 [TBL] [Abstract][Full Text] [Related]
10. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)]. Niksić M; Balogh M Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570 [TBL] [Abstract][Full Text] [Related]
11. Surface antigens of BK virus-induced tumor cells. Karjalainen HE Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387 [TBL] [Abstract][Full Text] [Related]
12. Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells. Hayashi H; Nio Y; Kawabata K; Araya S; Imamura M J Surg Oncol; 1996 Jul; 62(3):162-70. PubMed ID: 8667622 [TBL] [Abstract][Full Text] [Related]
13. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta). Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma. Mang WL; Hammer C J Med; 1981; 12(6):447-53. PubMed ID: 7033427 [TBL] [Abstract][Full Text] [Related]
15. Fate of HL-A antigens and antibodies at the lymphocyte surface. Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085 [No Abstract] [Full Text] [Related]
16. [Tumor specific surface antigens and immunological reaction of Rous sarcoma (review) (author's transl)]. Hayami M Uirusu; 1981 Jun; 31(1):1-20. PubMed ID: 6277085 [No Abstract] [Full Text] [Related]
17. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923 [TBL] [Abstract][Full Text] [Related]
18. Oncornavirus directed tumor cell surface antigens detectable by humoral and cellular immunity. Bauer H; Kurth R; Gelderblom H Johns Hopkins Med J Suppl; 1974; 3():445-54. PubMed ID: 4371550 [No Abstract] [Full Text] [Related]
19. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265 [TBL] [Abstract][Full Text] [Related]
20. Liposome encapsulated tumor-associated antigens elicited humoral and cellular immune responses in mice bearing tumor. Alam A; Imliwati L; Rapthap C; Singh V Indian J Exp Biol; 2001 Mar; 39(3):201-8. PubMed ID: 11495277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]